nodes	percent_of_prediction	percent_of_DWPC	metapath
Nevirapine—CYP1A2—Carmustine—melanoma	0.157	0.212	CbGbCtD
Nevirapine—CYP1A2—Vemurafenib—melanoma	0.124	0.167	CbGbCtD
Nevirapine—CYP3A4—Temozolomide—melanoma	0.119	0.16	CbGbCtD
Nevirapine—CYP2D6—Vemurafenib—melanoma	0.102	0.138	CbGbCtD
Nevirapine—CYP1A2—Dacarbazine—melanoma	0.0953	0.128	CbGbCtD
Nevirapine—CYP3A4—Vemurafenib—melanoma	0.0651	0.0877	CbGbCtD
Nevirapine—CYP3A5—Docetaxel—melanoma	0.0573	0.0771	CbGbCtD
Nevirapine—CYP3A4—Docetaxel—melanoma	0.0223	0.0301	CbGbCtD
Nevirapine—Rash papular—Vemurafenib—melanoma	0.00899	0.0372	CcSEcCtD
Nevirapine—Erythema nodosum—Vemurafenib—melanoma	0.00774	0.032	CcSEcCtD
Nevirapine—Traumatic liver injury—Temozolomide—melanoma	0.00459	0.019	CcSEcCtD
Nevirapine—Hepatotoxicity—Vemurafenib—melanoma	0.00434	0.0179	CcSEcCtD
Nevirapine—Opportunistic infection—Temozolomide—melanoma	0.00425	0.0176	CcSEcCtD
Nevirapine—Ulcerative stomatitis—Dactinomycin—melanoma	0.0041	0.017	CcSEcCtD
Nevirapine—Gamma-glutamyltransferase increased—Vemurafenib—melanoma	0.00407	0.0168	CcSEcCtD
Nevirapine—Rash maculo-papular—Vemurafenib—melanoma	0.00304	0.0126	CcSEcCtD
Nevirapine—Transaminases increased—Carmustine—melanoma	0.00291	0.012	CcSEcCtD
Nevirapine—Bullous eruption—Docetaxel—melanoma	0.00288	0.0119	CcSEcCtD
Nevirapine—Hepatotoxicity—Dactinomycin—melanoma	0.00245	0.0101	CcSEcCtD
Nevirapine—Necrosis—Dactinomycin—melanoma	0.00241	0.00997	CcSEcCtD
Nevirapine—Hepatotoxicity—Carmustine—melanoma	0.00229	0.00949	CcSEcCtD
Nevirapine—Necrosis—Carmustine—melanoma	0.00226	0.00933	CcSEcCtD
Nevirapine—Hepatotoxicity—Temozolomide—melanoma	0.00222	0.00917	CcSEcCtD
Nevirapine—Toxic epidermal necrolysis—Vemurafenib—melanoma	0.00219	0.00906	CcSEcCtD
Nevirapine—Ulcer—Bleomycin—melanoma	0.00214	0.00887	CcSEcCtD
Nevirapine—Gamma-glutamyltransferase increased—Temozolomide—melanoma	0.00208	0.00861	CcSEcCtD
Nevirapine—Eosinophilia—Vemurafenib—melanoma	0.00208	0.00861	CcSEcCtD
Nevirapine—Liver injury—Temozolomide—melanoma	0.00203	0.00841	CcSEcCtD
Nevirapine—Foetor hepaticus—Docetaxel—melanoma	0.002	0.0083	CcSEcCtD
Nevirapine—Ulcer—Dactinomycin—melanoma	0.002	0.00828	CcSEcCtD
Nevirapine—Skin exfoliation—Bleomycin—melanoma	0.00194	0.00801	CcSEcCtD
Nevirapine—Drug interaction—Carmustine—melanoma	0.00191	0.0079	CcSEcCtD
Nevirapine—Stevens-Johnson syndrome—Vemurafenib—melanoma	0.00186	0.00768	CcSEcCtD
Nevirapine—Neuropathy peripheral—Vemurafenib—melanoma	0.00184	0.0076	CcSEcCtD
Nevirapine—Hepatic enzyme increased—Temozolomide—melanoma	0.00181	0.00749	CcSEcCtD
Nevirapine—Mouth ulceration—Dactinomycin—melanoma	0.00171	0.00708	CcSEcCtD
Nevirapine—Skin exfoliation—Carmustine—melanoma	0.00169	0.00699	CcSEcCtD
Nevirapine—Liver disorder—Docetaxel—melanoma	0.00167	0.00691	CcSEcCtD
Nevirapine—Connective tissue disorder—Vemurafenib—melanoma	0.00165	0.00684	CcSEcCtD
Nevirapine—Skin exfoliation—Temozolomide—melanoma	0.00163	0.00676	CcSEcCtD
Nevirapine—Erythema multiforme—Vemurafenib—melanoma	0.00159	0.00658	CcSEcCtD
Nevirapine—Hepatic failure—Dactinomycin—melanoma	0.00153	0.00632	CcSEcCtD
Nevirapine—Rash erythematous—Docetaxel—melanoma	0.00149	0.00615	CcSEcCtD
Nevirapine—Hepatotoxicity—Docetaxel—melanoma	0.00147	0.0061	CcSEcCtD
Nevirapine—Erythema—Vemurafenib—melanoma	0.00146	0.00606	CcSEcCtD
Nevirapine—Necrosis—Docetaxel—melanoma	0.00145	0.006	CcSEcCtD
Nevirapine—Hepatic failure—Temozolomide—melanoma	0.00138	0.00572	CcSEcCtD
Nevirapine—Dermatitis exfoliative—Temozolomide—melanoma	0.00132	0.00545	CcSEcCtD
Nevirapine—Liver function test abnormal—Dactinomycin—melanoma	0.00127	0.00525	CcSEcCtD
Nevirapine—Bone disorder—Docetaxel—melanoma	0.00126	0.00521	CcSEcCtD
Nevirapine—Arthralgia—Vemurafenib—melanoma	0.00125	0.00516	CcSEcCtD
Nevirapine—Myalgia—Vemurafenib—melanoma	0.00125	0.00516	CcSEcCtD
Nevirapine—Face oedema—Carmustine—melanoma	0.00124	0.00513	CcSEcCtD
Nevirapine—Unspecified disorder of skin and subcutaneous tissue—Vemurafenib—melanoma	0.00124	0.00512	CcSEcCtD
Nevirapine—Toxic epidermal necrolysis—Dactinomycin—melanoma	0.00124	0.00512	CcSEcCtD
Nevirapine—Aspartate aminotransferase increased—Dactinomycin—melanoma	0.00124	0.00512	CcSEcCtD
Nevirapine—Drug interaction—Docetaxel—melanoma	0.00123	0.00508	CcSEcCtD
Nevirapine—Face oedema—Temozolomide—melanoma	0.0012	0.00496	CcSEcCtD
Nevirapine—Anaphylactic shock—Vemurafenib—melanoma	0.00119	0.00494	CcSEcCtD
Nevirapine—Liver function test abnormal—Carmustine—melanoma	0.00119	0.00491	CcSEcCtD
Nevirapine—Inflammation—Docetaxel—melanoma	0.00117	0.00485	CcSEcCtD
Nevirapine—Nervous system disorder—Vemurafenib—melanoma	0.00117	0.00485	CcSEcCtD
Nevirapine—Skin disorder—Vemurafenib—melanoma	0.00116	0.0048	CcSEcCtD
Nevirapine—Blood pressure increased—Docetaxel—melanoma	0.00114	0.00471	CcSEcCtD
Nevirapine—Hepatocellular injury—Docetaxel—melanoma	0.00114	0.00471	CcSEcCtD
Nevirapine—Toxic epidermal necrolysis—Temozolomide—melanoma	0.00112	0.00463	CcSEcCtD
Nevirapine—Aspartate aminotransferase increased—Temozolomide—melanoma	0.00112	0.00463	CcSEcCtD
Nevirapine—Neutropenia—Dactinomycin—melanoma	0.00111	0.00459	CcSEcCtD
Nevirapine—Alanine aminotransferase increased—Temozolomide—melanoma	0.0011	0.00453	CcSEcCtD
Nevirapine—Musculoskeletal discomfort—Vemurafenib—melanoma	0.00109	0.0045	CcSEcCtD
Nevirapine—Skin exfoliation—Docetaxel—melanoma	0.00109	0.00449	CcSEcCtD
Nevirapine—Stevens-Johnson syndrome—Dactinomycin—melanoma	0.00105	0.00434	CcSEcCtD
Nevirapine—Neutropenia—Carmustine—melanoma	0.00104	0.0043	CcSEcCtD
Nevirapine—Decreased appetite—Vemurafenib—melanoma	0.00104	0.0043	CcSEcCtD
Nevirapine—Gastrointestinal disorder—Vemurafenib—melanoma	0.00103	0.00427	CcSEcCtD
Nevirapine—Fatigue—Vemurafenib—melanoma	0.00103	0.00426	CcSEcCtD
Nevirapine—Neutropenia—Temozolomide—melanoma	0.001	0.00415	CcSEcCtD
Nevirapine—Hyperglycaemia—Carmustine—melanoma	0.001	0.00415	CcSEcCtD
Nevirapine—Agranulocytosis—Dactinomycin—melanoma	0.000987	0.00409	CcSEcCtD
Nevirapine—Renal failure—Carmustine—melanoma	0.000973	0.00403	CcSEcCtD
Nevirapine—Neuropathy peripheral—Carmustine—melanoma	0.000971	0.00402	CcSEcCtD
Nevirapine—Hyperglycaemia—Temozolomide—melanoma	0.000968	0.00401	CcSEcCtD
Nevirapine—Hepatitis—Dactinomycin—melanoma	0.00095	0.00393	CcSEcCtD
Nevirapine—Stevens-Johnson syndrome—Temozolomide—melanoma	0.000949	0.00393	CcSEcCtD
Nevirapine—Body temperature increased—Vemurafenib—melanoma	0.000944	0.00391	CcSEcCtD
Nevirapine—Neuropathy peripheral—Temozolomide—melanoma	0.000938	0.00388	CcSEcCtD
Nevirapine—Hepatic failure—Docetaxel—melanoma	0.000919	0.0038	CcSEcCtD
Nevirapine—Hepatobiliary disease—Temozolomide—melanoma	0.000905	0.00375	CcSEcCtD
Nevirapine—Erythema multiforme—Dactinomycin—melanoma	0.000898	0.00372	CcSEcCtD
Nevirapine—Erythema—Bleomycin—melanoma	0.000887	0.00367	CcSEcCtD
Nevirapine—Hypersensitivity—Vemurafenib—melanoma	0.00088	0.00364	CcSEcCtD
Nevirapine—Connective tissue disorder—Carmustine—melanoma	0.000874	0.00362	CcSEcCtD
Nevirapine—Dermatitis bullous—Docetaxel—melanoma	0.000864	0.00358	CcSEcCtD
Nevirapine—Hepatitis—Temozolomide—melanoma	0.000859	0.00356	CcSEcCtD
Nevirapine—Asthenia—Vemurafenib—melanoma	0.000857	0.00355	CcSEcCtD
Nevirapine—Pruritus—Vemurafenib—melanoma	0.000845	0.0035	CcSEcCtD
Nevirapine—Connective tissue disorder—Temozolomide—melanoma	0.000844	0.00349	CcSEcCtD
Nevirapine—Erythema—Dactinomycin—melanoma	0.000827	0.00342	CcSEcCtD
Nevirapine—Ill-defined disorder—Bleomycin—melanoma	0.000823	0.0034	CcSEcCtD
Nevirapine—Anaemia—Bleomycin—melanoma	0.000819	0.00339	CcSEcCtD
Nevirapine—Diarrhoea—Vemurafenib—melanoma	0.000817	0.00338	CcSEcCtD
Nevirapine—Erythema multiforme—Temozolomide—melanoma	0.000812	0.00336	CcSEcCtD
Nevirapine—Malaise—Bleomycin—melanoma	0.0008	0.00331	CcSEcCtD
Nevirapine—Immune system disorder—Temozolomide—melanoma	0.000776	0.00321	CcSEcCtD
Nevirapine—Erythema—Carmustine—melanoma	0.000774	0.0032	CcSEcCtD
Nevirapine—Ill-defined disorder—Dactinomycin—melanoma	0.000767	0.00317	CcSEcCtD
Nevirapine—Anaemia—Dactinomycin—melanoma	0.000764	0.00316	CcSEcCtD
Nevirapine—Liver function test abnormal—Docetaxel—melanoma	0.000762	0.00316	CcSEcCtD
Nevirapine—Vomiting—Vemurafenib—melanoma	0.000759	0.00314	CcSEcCtD
Nevirapine—Myalgia—Bleomycin—melanoma	0.000755	0.00312	CcSEcCtD
Nevirapine—Rash—Vemurafenib—melanoma	0.000753	0.00312	CcSEcCtD
Nevirapine—Dermatitis—Vemurafenib—melanoma	0.000752	0.00311	CcSEcCtD
Nevirapine—Headache—Vemurafenib—melanoma	0.000748	0.0031	CcSEcCtD
Nevirapine—Erythema—Temozolomide—melanoma	0.000748	0.00309	CcSEcCtD
Nevirapine—Discomfort—Bleomycin—melanoma	0.000746	0.00309	CcSEcCtD
Nevirapine—Malaise—Dactinomycin—melanoma	0.000746	0.00309	CcSEcCtD
Nevirapine—Toxic epidermal necrolysis—Docetaxel—melanoma	0.000744	0.00308	CcSEcCtD
Nevirapine—Aspartate aminotransferase increased—Docetaxel—melanoma	0.000744	0.00308	CcSEcCtD
Nevirapine—Alanine aminotransferase increased—Docetaxel—melanoma	0.000728	0.00301	CcSEcCtD
Nevirapine—Oedema—Bleomycin—melanoma	0.000724	0.00299	CcSEcCtD
Nevirapine—Anaphylactic shock—Bleomycin—melanoma	0.000724	0.00299	CcSEcCtD
Nevirapine—Anaemia—Carmustine—melanoma	0.000715	0.00296	CcSEcCtD
Nevirapine—Nausea—Vemurafenib—melanoma	0.000709	0.00294	CcSEcCtD
Nevirapine—Thrombocytopenia—Bleomycin—melanoma	0.000708	0.00293	CcSEcCtD
Nevirapine—Myalgia—Dactinomycin—melanoma	0.000704	0.00291	CcSEcCtD
Nevirapine—Discomfort—Dactinomycin—melanoma	0.000696	0.00288	CcSEcCtD
Nevirapine—Ill-defined disorder—Temozolomide—melanoma	0.000694	0.00287	CcSEcCtD
Nevirapine—Anaemia—Temozolomide—melanoma	0.000691	0.00286	CcSEcCtD
Nevirapine—Anorexia—Bleomycin—melanoma	0.00069	0.00285	CcSEcCtD
Nevirapine—Angioedema—Temozolomide—melanoma	0.000683	0.00283	CcSEcCtD
Nevirapine—Oedema—Dactinomycin—melanoma	0.000675	0.00279	CcSEcCtD
Nevirapine—Malaise—Temozolomide—melanoma	0.000674	0.00279	CcSEcCtD
Nevirapine—Neutropenia—Docetaxel—melanoma	0.000667	0.00276	CcSEcCtD
Nevirapine—Thrombocytopenia—Dactinomycin—melanoma	0.000661	0.00273	CcSEcCtD
Nevirapine—Musculoskeletal discomfort—Bleomycin—melanoma	0.000659	0.00273	CcSEcCtD
Nevirapine—Myalgia—Carmustine—melanoma	0.000659	0.00273	CcSEcCtD
Nevirapine—Paraesthesia—Bleomycin—melanoma	0.00065	0.00269	CcSEcCtD
Nevirapine—Anorexia—Dactinomycin—melanoma	0.000643	0.00266	CcSEcCtD
Nevirapine—Myalgia—Temozolomide—melanoma	0.000637	0.00263	CcSEcCtD
Nevirapine—Arthralgia—Temozolomide—melanoma	0.000637	0.00263	CcSEcCtD
Nevirapine—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.000632	0.00262	CcSEcCtD
Nevirapine—Oedema—Carmustine—melanoma	0.000632	0.00261	CcSEcCtD
Nevirapine—Stevens-Johnson syndrome—Docetaxel—melanoma	0.000631	0.00261	CcSEcCtD
Nevirapine—Discomfort—Temozolomide—melanoma	0.000629	0.0026	CcSEcCtD
Nevirapine—Decreased appetite—Bleomycin—melanoma	0.000629	0.0026	CcSEcCtD
Nevirapine—Renal failure—Docetaxel—melanoma	0.000626	0.00259	CcSEcCtD
Nevirapine—Neuropathy peripheral—Docetaxel—melanoma	0.000624	0.00258	CcSEcCtD
Nevirapine—Jaundice—Docetaxel—melanoma	0.00062	0.00257	CcSEcCtD
Nevirapine—Pain—Bleomycin—melanoma	0.000619	0.00256	CcSEcCtD
Nevirapine—Conjunctivitis—Docetaxel—melanoma	0.000619	0.00256	CcSEcCtD
Nevirapine—Thrombocytopenia—Carmustine—melanoma	0.000618	0.00256	CcSEcCtD
Nevirapine—Musculoskeletal discomfort—Dactinomycin—melanoma	0.000615	0.00254	CcSEcCtD
Nevirapine—Anaphylactic shock—Temozolomide—melanoma	0.00061	0.00253	CcSEcCtD
Nevirapine—Oedema—Temozolomide—melanoma	0.00061	0.00253	CcSEcCtD
Nevirapine—Anorexia—Carmustine—melanoma	0.000602	0.00249	CcSEcCtD
Nevirapine—Hepatobiliary disease—Docetaxel—melanoma	0.000602	0.00249	CcSEcCtD
Nevirapine—Nervous system disorder—Temozolomide—melanoma	0.000599	0.00248	CcSEcCtD
Nevirapine—Thrombocytopenia—Temozolomide—melanoma	0.000598	0.00247	CcSEcCtD
Nevirapine—Feeling abnormal—Bleomycin—melanoma	0.000596	0.00247	CcSEcCtD
Nevirapine—Agranulocytosis—Docetaxel—melanoma	0.000594	0.00246	CcSEcCtD
Nevirapine—Skin disorder—Temozolomide—melanoma	0.000593	0.00245	CcSEcCtD
Nevirapine—Decreased appetite—Dactinomycin—melanoma	0.000587	0.00243	CcSEcCtD
Nevirapine—Fatigue—Dactinomycin—melanoma	0.000582	0.00241	CcSEcCtD
Nevirapine—Anorexia—Temozolomide—melanoma	0.000582	0.00241	CcSEcCtD
Nevirapine—Pain—Dactinomycin—melanoma	0.000577	0.00239	CcSEcCtD
Nevirapine—Musculoskeletal discomfort—Carmustine—melanoma	0.000575	0.00238	CcSEcCtD
Nevirapine—Urticaria—Bleomycin—melanoma	0.000575	0.00238	CcSEcCtD
Nevirapine—Body temperature increased—Bleomycin—melanoma	0.000572	0.00237	CcSEcCtD
Nevirapine—Hepatitis—Docetaxel—melanoma	0.000571	0.00236	CcSEcCtD
Nevirapine—Paraesthesia—Carmustine—melanoma	0.000567	0.00235	CcSEcCtD
Nevirapine—Somnolence—Carmustine—melanoma	0.000562	0.00232	CcSEcCtD
Nevirapine—Connective tissue disorder—Docetaxel—melanoma	0.000561	0.00232	CcSEcCtD
Nevirapine—Feeling abnormal—Dactinomycin—melanoma	0.000556	0.0023	CcSEcCtD
Nevirapine—Musculoskeletal discomfort—Temozolomide—melanoma	0.000556	0.0023	CcSEcCtD
Nevirapine—Gastrointestinal pain—Dactinomycin—melanoma	0.000552	0.00228	CcSEcCtD
Nevirapine—Decreased appetite—Carmustine—melanoma	0.000549	0.00227	CcSEcCtD
Nevirapine—Paraesthesia—Temozolomide—melanoma	0.000548	0.00227	CcSEcCtD
Nevirapine—Gastrointestinal disorder—Carmustine—melanoma	0.000545	0.00226	CcSEcCtD
Nevirapine—Somnolence—Temozolomide—melanoma	0.000543	0.00225	CcSEcCtD
Nevirapine—Erythema multiforme—Docetaxel—melanoma	0.00054	0.00224	CcSEcCtD
Nevirapine—Pain—Carmustine—melanoma	0.00054	0.00224	CcSEcCtD
Nevirapine—Abdominal pain—Dactinomycin—melanoma	0.000533	0.00221	CcSEcCtD
Nevirapine—Body temperature increased—Dactinomycin—melanoma	0.000533	0.00221	CcSEcCtD
Nevirapine—Hypersensitivity—Bleomycin—melanoma	0.000533	0.00221	CcSEcCtD
Nevirapine—Decreased appetite—Temozolomide—melanoma	0.000531	0.0022	CcSEcCtD
Nevirapine—Gastrointestinal disorder—Temozolomide—melanoma	0.000527	0.00218	CcSEcCtD
Nevirapine—Fatigue—Temozolomide—melanoma	0.000526	0.00218	CcSEcCtD
Nevirapine—Pain—Temozolomide—melanoma	0.000522	0.00216	CcSEcCtD
Nevirapine—Feeling abnormal—Carmustine—melanoma	0.00052	0.00215	CcSEcCtD
Nevirapine—Asthenia—Bleomycin—melanoma	0.000519	0.00215	CcSEcCtD
Nevirapine—Gastrointestinal pain—Carmustine—melanoma	0.000516	0.00214	CcSEcCtD
Nevirapine—Immune system disorder—Docetaxel—melanoma	0.000516	0.00214	CcSEcCtD
Nevirapine—Pruritus—Bleomycin—melanoma	0.000512	0.00212	CcSEcCtD
Nevirapine—Feeling abnormal—Temozolomide—melanoma	0.000503	0.00208	CcSEcCtD
Nevirapine—Abdominal pain—Carmustine—melanoma	0.000499	0.00207	CcSEcCtD
Nevirapine—Body temperature increased—Carmustine—melanoma	0.000499	0.00207	CcSEcCtD
Nevirapine—Gastrointestinal pain—Temozolomide—melanoma	0.000499	0.00207	CcSEcCtD
Nevirapine—Erythema—Docetaxel—melanoma	0.000497	0.00206	CcSEcCtD
Nevirapine—Hypersensitivity—Dactinomycin—melanoma	0.000497	0.00206	CcSEcCtD
Nevirapine—Urticaria—Temozolomide—melanoma	0.000485	0.00201	CcSEcCtD
Nevirapine—Asthenia—Dactinomycin—melanoma	0.000484	0.002	CcSEcCtD
Nevirapine—Body temperature increased—Temozolomide—melanoma	0.000483	0.002	CcSEcCtD
Nevirapine—Abdominal pain—Temozolomide—melanoma	0.000483	0.002	CcSEcCtD
Nevirapine—Hypersensitivity—Carmustine—melanoma	0.000465	0.00193	CcSEcCtD
Nevirapine—Diarrhoea—Dactinomycin—melanoma	0.000462	0.00191	CcSEcCtD
Nevirapine—Vomiting—Bleomycin—melanoma	0.00046	0.0019	CcSEcCtD
Nevirapine—Anaemia—Docetaxel—melanoma	0.00046	0.0019	CcSEcCtD
Nevirapine—Rash—Bleomycin—melanoma	0.000456	0.00189	CcSEcCtD
Nevirapine—Dermatitis—Bleomycin—melanoma	0.000456	0.00189	CcSEcCtD
Nevirapine—Asthenia—Carmustine—melanoma	0.000453	0.00188	CcSEcCtD
Nevirapine—Hypersensitivity—Temozolomide—melanoma	0.00045	0.00186	CcSEcCtD
Nevirapine—Asthenia—Temozolomide—melanoma	0.000438	0.00181	CcSEcCtD
Nevirapine—Diarrhoea—Carmustine—melanoma	0.000432	0.00179	CcSEcCtD
Nevirapine—Pruritus—Temozolomide—melanoma	0.000432	0.00179	CcSEcCtD
Nevirapine—Nausea—Bleomycin—melanoma	0.00043	0.00178	CcSEcCtD
Nevirapine—Vomiting—Dactinomycin—melanoma	0.000429	0.00178	CcSEcCtD
Nevirapine—Rash—Dactinomycin—melanoma	0.000426	0.00176	CcSEcCtD
Nevirapine—Arthralgia—Docetaxel—melanoma	0.000423	0.00175	CcSEcCtD
Nevirapine—Myalgia—Docetaxel—melanoma	0.000423	0.00175	CcSEcCtD
Nevirapine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.000421	0.00174	CcSEcCtD
Nevirapine—Diarrhoea—Temozolomide—melanoma	0.000418	0.00173	CcSEcCtD
Nevirapine—Anaphylactic shock—Docetaxel—melanoma	0.000406	0.00168	CcSEcCtD
Nevirapine—Oedema—Docetaxel—melanoma	0.000406	0.00168	CcSEcCtD
Nevirapine—Vomiting—Carmustine—melanoma	0.000402	0.00166	CcSEcCtD
Nevirapine—Nausea—Dactinomycin—melanoma	0.000401	0.00166	CcSEcCtD
Nevirapine—Rash—Carmustine—melanoma	0.000398	0.00165	CcSEcCtD
Nevirapine—Nervous system disorder—Docetaxel—melanoma	0.000398	0.00165	CcSEcCtD
Nevirapine—Dermatitis—Carmustine—melanoma	0.000398	0.00165	CcSEcCtD
Nevirapine—Thrombocytopenia—Docetaxel—melanoma	0.000397	0.00164	CcSEcCtD
Nevirapine—Headache—Carmustine—melanoma	0.000396	0.00164	CcSEcCtD
Nevirapine—Skin disorder—Docetaxel—melanoma	0.000394	0.00163	CcSEcCtD
Nevirapine—Vomiting—Temozolomide—melanoma	0.000388	0.00161	CcSEcCtD
Nevirapine—Anorexia—Docetaxel—melanoma	0.000387	0.0016	CcSEcCtD
Nevirapine—Rash—Temozolomide—melanoma	0.000385	0.00159	CcSEcCtD
Nevirapine—Dermatitis—Temozolomide—melanoma	0.000385	0.00159	CcSEcCtD
Nevirapine—Headache—Temozolomide—melanoma	0.000382	0.00158	CcSEcCtD
Nevirapine—Nausea—Carmustine—melanoma	0.000375	0.00155	CcSEcCtD
Nevirapine—Musculoskeletal discomfort—Docetaxel—melanoma	0.00037	0.00153	CcSEcCtD
Nevirapine—Paraesthesia—Docetaxel—melanoma	0.000364	0.00151	CcSEcCtD
Nevirapine—Nausea—Temozolomide—melanoma	0.000363	0.0015	CcSEcCtD
Nevirapine—Somnolence—Docetaxel—melanoma	0.000361	0.00149	CcSEcCtD
Nevirapine—Decreased appetite—Docetaxel—melanoma	0.000353	0.00146	CcSEcCtD
Nevirapine—Gastrointestinal disorder—Docetaxel—melanoma	0.00035	0.00145	CcSEcCtD
Nevirapine—Fatigue—Docetaxel—melanoma	0.00035	0.00145	CcSEcCtD
Nevirapine—Pain—Docetaxel—melanoma	0.000347	0.00144	CcSEcCtD
Nevirapine—Feeling abnormal—Docetaxel—melanoma	0.000334	0.00138	CcSEcCtD
Nevirapine—Gastrointestinal pain—Docetaxel—melanoma	0.000332	0.00137	CcSEcCtD
Nevirapine—Body temperature increased—Docetaxel—melanoma	0.000321	0.00133	CcSEcCtD
Nevirapine—Abdominal pain—Docetaxel—melanoma	0.000321	0.00133	CcSEcCtD
Nevirapine—Hypersensitivity—Docetaxel—melanoma	0.000299	0.00124	CcSEcCtD
Nevirapine—Asthenia—Docetaxel—melanoma	0.000291	0.00121	CcSEcCtD
Nevirapine—Pruritus—Docetaxel—melanoma	0.000287	0.00119	CcSEcCtD
Nevirapine—Diarrhoea—Docetaxel—melanoma	0.000278	0.00115	CcSEcCtD
Nevirapine—Vomiting—Docetaxel—melanoma	0.000258	0.00107	CcSEcCtD
Nevirapine—Rash—Docetaxel—melanoma	0.000256	0.00106	CcSEcCtD
Nevirapine—Dermatitis—Docetaxel—melanoma	0.000256	0.00106	CcSEcCtD
Nevirapine—Headache—Docetaxel—melanoma	0.000254	0.00105	CcSEcCtD
Nevirapine—Nausea—Docetaxel—melanoma	0.000241	0.000998	CcSEcCtD
Nevirapine—CYP2A6—Metabolism—SDHD—melanoma	1.32e-05	0.00085	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—CSPG4—melanoma	1.32e-05	0.00085	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—BSG—melanoma	1.32e-05	0.00085	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—SLC6A11—melanoma	1.29e-05	0.000832	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—PIP4K2A—melanoma	1.29e-05	0.000832	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—HS3ST5—melanoma	1.29e-05	0.00083	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—MTAP—melanoma	1.29e-05	0.000828	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—ACER3—melanoma	1.29e-05	0.000827	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—GPAM—melanoma	1.28e-05	0.000824	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—HS3ST5—melanoma	1.28e-05	0.000823	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—MTAP—melanoma	1.26e-05	0.000809	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—UGT2B10—melanoma	1.18e-05	0.000757	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G6—melanoma	1.16e-05	0.000747	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—PHGDH—melanoma	1.15e-05	0.000738	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—LUM—melanoma	1.15e-05	0.000738	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—HPSE—melanoma	1.13e-05	0.000724	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—LUM—melanoma	1.12e-05	0.000721	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—PHGDH—melanoma	1.12e-05	0.000721	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—CUBN—melanoma	1.11e-05	0.00071	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—HPSE—melanoma	1.1e-05	0.000707	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—HS3ST5—melanoma	1.09e-05	0.000703	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—PLA2G6—melanoma	1.09e-05	0.0007	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—CUBN—melanoma	1.08e-05	0.000694	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—SDHD—melanoma	1.07e-05	0.000686	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—BSG—melanoma	1.07e-05	0.000686	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—CSPG4—melanoma	1.07e-05	0.000686	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—SDHD—melanoma	1.04e-05	0.000671	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—CSPG4—melanoma	1.04e-05	0.000671	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—BSG—melanoma	1.04e-05	0.000671	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—GPAM—melanoma	1.03e-05	0.000664	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism of lipids and lipoproteins—CYP17A1—melanoma	1.03e-05	0.000662	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—GPAM—melanoma	1.01e-05	0.000649	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—ACER3—melanoma	9.94e-06	0.000638	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—PLCB4—melanoma	9.79e-06	0.000629	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—VCAN—melanoma	9.79e-06	0.000629	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—PLCB4—melanoma	9.71e-06	0.000624	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism of lipids and lipoproteins—FASN—melanoma	9.53e-06	0.000612	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—PIP4K2A—melanoma	9.21e-06	0.000592	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—SLC6A11—melanoma	9.21e-06	0.000592	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—SLC6A11—melanoma	9.13e-06	0.000586	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—PIP4K2A—melanoma	9.13e-06	0.000586	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—UGT2B10—melanoma	9.09e-06	0.000584	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—MTAP—melanoma	8.96e-06	0.000575	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—MTAP—melanoma	8.88e-06	0.00057	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism of lipids and lipoproteins—CYP17A1—melanoma	8.81e-06	0.000566	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—PLA2G6—melanoma	8.79e-06	0.000565	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	8.68e-06	0.000558	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—PLA2G6—melanoma	8.59e-06	0.000552	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—HS3ST5—melanoma	8.45e-06	0.000543	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—PLCB4—melanoma	8.3e-06	0.000533	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—CYP17A1—melanoma	8.26e-06	0.000531	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism of lipids and lipoproteins—FASN—melanoma	8.14e-06	0.000523	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—LUM—melanoma	7.98e-06	0.000513	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—PHGDH—melanoma	7.98e-06	0.000513	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—LUM—melanoma	7.91e-06	0.000508	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—PHGDH—melanoma	7.91e-06	0.000508	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—VCAN—melanoma	7.9e-06	0.000507	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—HPSE—melanoma	7.83e-06	0.000503	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—GNA11—melanoma	7.8e-06	0.000501	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—SLC6A11—melanoma	7.8e-06	0.000501	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—PIP4K2A—melanoma	7.8e-06	0.000501	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—HPSE—melanoma	7.76e-06	0.000499	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—VCAN—melanoma	7.72e-06	0.000496	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—CUBN—melanoma	7.68e-06	0.000494	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—FASN—melanoma	7.63e-06	0.00049	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—CUBN—melanoma	7.62e-06	0.000489	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—MTAP—melanoma	7.59e-06	0.000488	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—SLC5A5—melanoma	7.51e-06	0.000482	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—SDHD—melanoma	7.42e-06	0.000477	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—BSG—melanoma	7.42e-06	0.000477	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—CSPG4—melanoma	7.42e-06	0.000477	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	7.42e-06	0.000476	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—SDHD—melanoma	7.36e-06	0.000473	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—CSPG4—melanoma	7.36e-06	0.000473	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—BSG—melanoma	7.36e-06	0.000473	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—CD44—melanoma	7.25e-06	0.000466	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—GNAQ—melanoma	7.25e-06	0.000466	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—GPAM—melanoma	7.19e-06	0.000462	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—GPAM—melanoma	7.13e-06	0.000458	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—CYP1B1—melanoma	6.95e-06	0.000447	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—PHGDH—melanoma	6.76e-06	0.000435	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—LUM—melanoma	6.76e-06	0.000435	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—CYP17A1—melanoma	6.66e-06	0.000428	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—HPSE—melanoma	6.63e-06	0.000426	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—CYP17A1—melanoma	6.51e-06	0.000419	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—CUBN—melanoma	6.51e-06	0.000418	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—PLCB4—melanoma	6.4e-06	0.000411	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—GNA11—melanoma	6.29e-06	0.000404	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—SDHD—melanoma	6.29e-06	0.000404	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—BSG—melanoma	6.29e-06	0.000404	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—CSPG4—melanoma	6.29e-06	0.000404	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—FASN—melanoma	6.16e-06	0.000396	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—GNA11—melanoma	6.15e-06	0.000395	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—PLA2G6—melanoma	6.11e-06	0.000393	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—GPAM—melanoma	6.09e-06	0.000391	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—PLA2G6—melanoma	6.06e-06	0.000389	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—SLC5A5—melanoma	6.06e-06	0.000389	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—PIP4K2A—melanoma	6.02e-06	0.000387	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—SLC6A11—melanoma	6.02e-06	0.000387	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—FASN—melanoma	6.02e-06	0.000387	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—SLC5A5—melanoma	5.92e-06	0.00038	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—MTAP—melanoma	5.86e-06	0.000376	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—GNAQ—melanoma	5.85e-06	0.000376	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—CD44—melanoma	5.85e-06	0.000376	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—ABCB1—melanoma	5.72e-06	0.000368	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—GNAQ—melanoma	5.72e-06	0.000367	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—CD44—melanoma	5.72e-06	0.000367	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—CYP1B1—melanoma	5.61e-06	0.00036	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—VCAN—melanoma	5.49e-06	0.000353	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—CYP1B1—melanoma	5.48e-06	0.000352	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—VCAN—melanoma	5.44e-06	0.00035	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—PRKCA—melanoma	5.27e-06	0.000339	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—ERCC2—melanoma	5.23e-06	0.000336	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—LUM—melanoma	5.22e-06	0.000335	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—PHGDH—melanoma	5.22e-06	0.000335	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—PLA2G6—melanoma	5.18e-06	0.000333	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	5.15e-06	0.000331	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—HPSE—melanoma	5.12e-06	0.000329	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—CUBN—melanoma	5.02e-06	0.000323	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—melanoma	4.97e-06	0.000319	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—SDHD—melanoma	4.85e-06	0.000312	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—BSG—melanoma	4.85e-06	0.000312	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—CSPG4—melanoma	4.85e-06	0.000312	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—GPAM—melanoma	4.7e-06	0.000302	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—VCAN—melanoma	4.65e-06	0.000299	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—CYP17A1—melanoma	4.63e-06	0.000298	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—ABCB1—melanoma	4.62e-06	0.000297	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—CYP17A1—melanoma	4.59e-06	0.000295	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	4.53e-06	0.000291	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—ABCB1—melanoma	4.51e-06	0.00029	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—melanoma	4.47e-06	0.000287	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	4.4e-06	0.000283	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—GNA11—melanoma	4.37e-06	0.000281	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—GNA11—melanoma	4.34e-06	0.000279	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—FASN—melanoma	4.28e-06	0.000275	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—PRKCA—melanoma	4.25e-06	0.000273	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—melanoma	4.25e-06	0.000273	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—FASN—melanoma	4.24e-06	0.000273	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—ERCC2—melanoma	4.22e-06	0.000271	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—SLC5A5—melanoma	4.21e-06	0.000271	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—SLC5A5—melanoma	4.17e-06	0.000268	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—PRKCA—melanoma	4.15e-06	0.000267	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—PIK3CG—melanoma	4.13e-06	0.000265	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—ERCC2—melanoma	4.12e-06	0.000265	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—GNAQ—melanoma	4.07e-06	0.000261	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—CD44—melanoma	4.07e-06	0.000261	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—GNAQ—melanoma	4.03e-06	0.000259	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—CD44—melanoma	4.03e-06	0.000259	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—PLA2G6—melanoma	4e-06	0.000257	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—PPARG—melanoma	3.98e-06	0.000256	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	3.95e-06	0.000254	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—CYP17A1—melanoma	3.92e-06	0.000252	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—melanoma	3.91e-06	0.000251	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—CYP1B1—melanoma	3.9e-06	0.00025	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	3.87e-06	0.000249	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—CYP1B1—melanoma	3.86e-06	0.000248	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—melanoma	3.82e-06	0.000245	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—GNA11—melanoma	3.71e-06	0.000238	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—PIK3CD—melanoma	3.63e-06	0.000233	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—FASN—melanoma	3.63e-06	0.000233	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—VCAN—melanoma	3.59e-06	0.000231	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—ALB—melanoma	3.58e-06	0.00023	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—SLC5A5—melanoma	3.57e-06	0.000229	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—GNAQ—melanoma	3.44e-06	0.000221	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—CD44—melanoma	3.44e-06	0.000221	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—melanoma	3.41e-06	0.000219	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	3.37e-06	0.000217	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—melanoma	3.34e-06	0.000215	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—PIK3CG—melanoma	3.33e-06	0.000214	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—CYP1B1—melanoma	3.3e-06	0.000212	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—PIK3CG—melanoma	3.25e-06	0.000209	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—PPARG—melanoma	3.21e-06	0.000206	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—ABCB1—melanoma	3.21e-06	0.000206	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—ABCB1—melanoma	3.18e-06	0.000204	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—PIK3CB—melanoma	3.16e-06	0.000203	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—PPARG—melanoma	3.14e-06	0.000202	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—PTGS2—melanoma	3.13e-06	0.000201	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—CYP17A1—melanoma	3.03e-06	0.000195	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—PRKCA—melanoma	2.95e-06	0.00019	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—ERCC2—melanoma	2.93e-06	0.000188	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—PRKCA—melanoma	2.93e-06	0.000188	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—PIK3CD—melanoma	2.93e-06	0.000188	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—melanoma	2.91e-06	0.000187	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—ERCC2—melanoma	2.9e-06	0.000187	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—ALB—melanoma	2.89e-06	0.000186	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—PIK3CD—melanoma	2.86e-06	0.000184	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—GNA11—melanoma	2.86e-06	0.000184	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—ALB—melanoma	2.82e-06	0.000181	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—FASN—melanoma	2.8e-06	0.00018	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—SLC5A5—melanoma	2.75e-06	0.000177	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—PTEN—melanoma	2.73e-06	0.000176	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—ABCB1—melanoma	2.72e-06	0.000175	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—GNAQ—melanoma	2.66e-06	0.000171	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—CD44—melanoma	2.66e-06	0.000171	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—PIK3CB—melanoma	2.55e-06	0.000164	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—CYP1B1—melanoma	2.55e-06	0.000164	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—PTGS2—melanoma	2.53e-06	0.000162	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—PRKCA—melanoma	2.5e-06	0.000161	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—PIK3CB—melanoma	2.49e-06	0.00016	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—ERCC2—melanoma	2.48e-06	0.000159	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—PTGS2—melanoma	2.47e-06	0.000159	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	2.41e-06	0.000155	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—PIK3CG—melanoma	2.31e-06	0.000149	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—PIK3CG—melanoma	2.29e-06	0.000147	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—PPARG—melanoma	2.23e-06	0.000144	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—PPARG—melanoma	2.21e-06	0.000142	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—PTEN—melanoma	2.2e-06	0.000142	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—PTEN—melanoma	2.15e-06	0.000138	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—ABCB1—melanoma	2.1e-06	0.000135	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	2.06e-06	0.000132	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—PIK3CD—melanoma	2.03e-06	0.000131	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—PIK3CD—melanoma	2.02e-06	0.00013	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—ALB—melanoma	2.01e-06	0.000129	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—ALB—melanoma	1.99e-06	0.000128	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—PIK3CG—melanoma	1.96e-06	0.000126	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—PRKCA—melanoma	1.93e-06	0.000124	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—PIK3CA—melanoma	1.93e-06	0.000124	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—ERCC2—melanoma	1.92e-06	0.000123	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—PPARG—melanoma	1.89e-06	0.000122	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—PIK3CB—melanoma	1.77e-06	0.000114	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—PIK3CB—melanoma	1.76e-06	0.000113	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—PTGS2—melanoma	1.76e-06	0.000113	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—PTGS2—melanoma	1.74e-06	0.000112	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—PIK3CD—melanoma	1.72e-06	0.000111	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—ALB—melanoma	1.7e-06	0.000109	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—AKT1—melanoma	1.57e-06	0.000101	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—PIK3CA—melanoma	1.56e-06	9.99e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—PTEN—melanoma	1.53e-06	9.85e-05	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—PIK3CA—melanoma	1.52e-06	9.77e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—PTEN—melanoma	1.52e-06	9.76e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—PIK3CG—melanoma	1.51e-06	9.72e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—PIK3CB—melanoma	1.5e-06	9.65e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—PTGS2—melanoma	1.49e-06	9.56e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—PPARG—melanoma	1.46e-06	9.38e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—PIK3CD—melanoma	1.33e-06	8.55e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—ALB—melanoma	1.31e-06	8.44e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—PTEN—melanoma	1.3e-06	8.34e-05	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—AKT1—melanoma	1.27e-06	8.16e-05	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—AKT1—melanoma	1.24e-06	7.98e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—PIK3CB—melanoma	1.16e-06	7.45e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—PTGS2—melanoma	1.15e-06	7.38e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—PIK3CA—melanoma	1.08e-06	6.95e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—PIK3CA—melanoma	1.07e-06	6.89e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—PTEN—melanoma	1e-06	6.44e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—PIK3CA—melanoma	9.16e-07	5.88e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—AKT1—melanoma	8.83e-07	5.67e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—AKT1—melanoma	8.75e-07	5.62e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—AKT1—melanoma	7.48e-07	4.81e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—PIK3CA—melanoma	7.07e-07	4.54e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—AKT1—melanoma	5.77e-07	3.71e-05	CbGpPWpGaD
